{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:35:35Z","timestamp":1792488935420,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1052616"],"award-info":[{"award-number":["1052616"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.virol.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T11:46:29Z","timestamp":1546515989000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Is host heparanase required for the rapid spread of heparan sulfate binding viruses?"],"prefix":"10.1016","volume":"529","author":[{"given":"Mayank","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charani","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Vlodavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.virol.2019.01.001_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/brv.12034","article-title":"Glycosaminoglycans in infectious disease","volume":"88","author":"Kamhi","year":"2013","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.virol.2019.01.001_bib2","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.000921","article-title":"Heparan sulfate as a receptor for poxvirus infections and as a target for antiviral agents","author":"Khanna","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2318(01)57017-1","article-title":"Structure and biological interactions of heparin and heparan sulfate","volume":"57","author":"Casu","year":"2001","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"issue":"4","key":"10.1016\/j.virol.2019.01.001_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00018-004-4293-7","article-title":"Heparan sulfate-protein interactions: therapeutic potential through structure-function insights","volume":"62","author":"Coombe","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.virol.2019.01.001_bib5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission","volume":"2","author":"Bouvier","year":"2010","journal-title":"Virus.Basel"},{"issue":"3","key":"10.1016\/j.virol.2019.01.001_bib6","first-page":"M99","article-title":"Heparanase: a key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.virol.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.celrep.2017.06.041","article-title":"Viral activation of heparanase drives pathogenesis of herpes simplex virus-1","volume":"20","author":"Agelidis","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1038\/ncomms7985","article-title":"Heparanase is a host enzyme required for herpes simplex virus-1 release from cells","volume":"6","author":"Hadigal","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.virol.2019.01.001_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005181","article-title":"Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases","volume":"4","author":"Zcharia","year":"2009","journal-title":"PLos One"},{"issue":"5","key":"10.1016\/j.virol.2019.01.001_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/vim.2011.0020","article-title":"Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-beta","volume":"24","author":"Zhao","year":"2011","journal-title":"Viral Immunol."},{"issue":"5","key":"10.1016\/j.virol.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/JVI.01655-08","article-title":"Role for CCR5 in dissemination of vaccinia virus in vivo","volume":"83","author":"Rahbar","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.001_bib12","doi-asserted-by":"crossref","unstructured":"Esko, J.D., Stewart, T.E., Taylor, W.H., 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. In: Proceedings of the National Academy of Sciences of the United States of America. 82(10): pp. 3197\u20133201.","DOI":"10.1073\/pnas.82.10.3197"},{"issue":"2","key":"10.1016\/j.virol.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1006\/viro.1995.1021","article-title":"Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis","volume":"206","author":"Ramsey-Ewing","year":"1995","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2019.01.001_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0168-1702(85)90037-1","article-title":"Expression and regulation of the Vaccinia virus thymidine kinase gene in non-permissive cells","volume":"3","author":"Franke","year":"1985","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.virol.2019.01.001_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1128\/jvi.28.3.843-850.1978","article-title":"Host range restriction of vaccinia virus in chinese hamster ovary cells - relationship to shutoff of protein synthesis","volume":"28","author":"Drillien","year":"1978","journal-title":"J. Virol."},{"issue":"37","key":"10.1016\/j.virol.2019.01.001_bib16","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2019.01.001_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/bj3301341","article-title":"Human platelet heparanase: purification, characterization and catalytic activity","volume":"330","author":"Freeman","year":"1998","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.virol.2019.01.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.virol.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virusres.2004.08.015","article-title":"The exit of Vaccinia virus from infected cells","volume":"106","author":"Smith","year":"2004","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.virol.2019.01.001_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JVI.01894-15","article-title":"Natural killer cells and innate interferon gamma participate in the host defense against respiratory vaccinia virus infection","volume":"90","author":"Abboud","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2019.01.001_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jhep.2008.12.023","article-title":"Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage","volume":"50","author":"Liu","year":"2009","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.virol.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-10-2476","article-title":"SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase\/syndecan-1 axis","volume":"17","author":"Ritchie","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.virol.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/bjc.2011.11","article-title":"PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models","volume":"104","author":"Dredge","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.virol.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"e21106","DOI":"10.1371\/journal.pone.0021106","article-title":"M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.virol.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc-2016-0012","article-title":"Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases","volume":"8","author":"Rivara","year":"2016","journal-title":"Future Med. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.virol.2019.01.001_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respir. Virus."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219300017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219300017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:47:31Z","timestamp":1758588451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682219300017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"alternative-id":["S0042682219300017"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2019.01.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is host heparanase required for the rapid spread of heparan sulfate binding viruses?","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}